Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Jun 09, 2022 |
Director
Trans History: 11
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 164,422 | -- | 164,422 |
Jun 09, 2022 |
Director
Trans History: 9
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 164,422 | -- | 164,422 |
Jun 09, 2022 |
Director
Trans History: 3
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 164,422 | -- | 164,422 |
Jun 09, 2022 |
Director
Trans History: 14
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 164,422 | -- | 164,422 |
Jun 09, 2022 |
Director
Trans History: 8
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 164,422 | -- | 164,422 |
Jun 09, 2022 |
Director
Trans History: 2
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 164,422 | -- | 164,422 |
May 16, 2022 |
Director
Trans History: 18
|
Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 10,000 | $1.60 | 13,894 |
May 16, 2022 |
Director, President and CEO
Trans History: 27
|
Director, President and CEO | Form 4 | Other acquisition or disposition | -- | -- | 5,025 |
May 13, 2022 |
Chief Financial Officer
Trans History: 14
|
Chief Financial Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 60,000 | $0.56 | 121,579 |
May 13, 2022 |
Chief Financial Officer
Trans History: 14
|
Chief Financial Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 60,000 | -- | 117,500 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.